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Abstract: 
  
The main objective of this project was to develop and validate methods for detection and 
analysis of proteins using a newly introduced microdrop plate reader equipped with a 16 well 
microdrop reader (2 uL sample volume). We used commercially available BSA, egg albumin, 
trypsinogen, Pepsin, β-lactoblobulin and lysozyme as out test moieties. Protein drop size, time, 
BCA reagent quantity, was assessed at various levels using a microdrop micro-BCA protocol 
(Pierce Chemical Company) with the appropriate controls (PBS blank) the method validated 
using the appropriate statistical and method parameters (i.e %RSD, and regression analysis of the 
standard curves). The micro method was used to determine the concentration of 5 known proteins 
and the method compared to the standard 96 well BCA plate method. The overarching strategy in 
our group is to develop, simple robust assays that use minimal sample amounts and reagents 
given the high cost and limited availability of many proteins and reagents (not to mention limiting 
waste disposal).  Moreover, the technique will aid researches in quickly identifying and analyzing 
proteins during expression, analysis, and isolation.     
 
Introduction: 
Because of wide range of protein functions, it is necessary to determine the 
concentration of protein in complex mixture. Estimation of concentration is necessary for 
protein analysis, protein purification, to study cells and other research applications. 
Protein assays are the most convenient tools for this purpose. There are many methods 
available to determine protein content, such as biuret assay, weight analysis, absorbance 
assays; each method is having certain limitation. Below are the main two types of protein 
assays. 
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     1. Absorbance assays i.e absorbance at 205 nm, absorbance at 280 nm, extinction  
coefficient 
     2. Colorimetric assays i.e biuret assay, BCA assay, Bradford assay, modified Lowry 
assay. 
 All assays involve estimation of protein concentration from measurements obtained from 
serial dilutions of a standard solution. The selection of assay depends on compatibility 
with the sample, sample volume, level of sensitivity ,presence or absence of interfering 
agents4. Among these various methods, colorimetric methods are commonly used 
because they offer more accuracy and convenience6. 
 
Bradford Assay :  
It is the dye binding assay that involves the change in the color of the dye which 
changes accordingly with the change in the concentration of a protein. Bradford assay 
involves the use of Coomassie Blue G-250 dye. It is the dimethylated form of Coomassie 
Brilliant Blue dye and it has a greenish tint.  
Chemical properties of dye are as follows :  
Chemical formula : C47H48N3NaO7S2  
Molecular weight : 854.02 g/mol  
Coomassie dye exists in three forms – cationic (red colored) , neutral ( green colored ) and 
anionic ( blue colored )7. Under acidic conditions, dye is in cationic form(Amax =470 nm). 
When it is bound to protein, it is converted to blue-colored complex which is measured at 
595 nm. 
 
BCA Assay: 
Chemical formula of Bicinchoninic acid:  (HO2CC9H5N)2   
Molecular weight of Bicinchoninic acid: 344.33 g/mole  
The BCA assay is a reduction assay of Cu2+ to Cu1+ in an alkaline medium by a protein. It mainly 
involves two steps. 
• The chelation of copper with the protein in an alkaline medium, resulting in the formation 
of light blue color. This reaction is called biuret reaction. 
• The BSA reagent reacts with the reduced cuprous ion formed in the previous step. Purple 
color now formed is due to the chelation of two molecules of BCA with one cuprous ion. 
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The complex thus formed is water soluble and its absorbance can effectively be measured at 
562nm. 
This method is now used to develop a method for analyzing the protein. The development of the 
method includes identifying the ideal drop size to be used in the micro drop plate reader and the 
ideal lay over time. BSA assay is preffered over the Bradford assay as the BSA gives good 
linearity. 
  Instruments: 
• Epoch Microplate spectrophotometer: It as 200 nm to 999 nm wavelength range with a 
microplate reading capacity of 6 to 384. It is also included with Gen5 microplate data 
analysis software. Another feature is that it offers compatibility with 96 well plate and 
Take-3 microplate which can be used for low volume protein quantification. 
• Humidified incubator : It is used to incubate the protein mixture. 
• Micro-pipette 
  
 Materials and reagents: 
1. Bovine Serum Albumin ( lot # 119K1673 ) from Sigma Aldrich. 
2. BCA kit : Bicinchoninic acid solution , Copper(II)sulfate solution from Sigma Aldrich 
3. Coomassie blue G-250 dye  ( lot # KD132217 ) from Thermo Scientific 
4. Phosphate-buffered saline (lot # 21040174) from Mediatech, Inc. 
5. Egg albumin 
6. Trypsinogen 
7. Pepsin 
8. β-lactoblobulin 
9. lysozyme 
10. Parafilm “M” 
 
9 | P a g e  
 
 
 
 
 
Methodology: 
Preperation of the reagents: 
• BSA reagent 
490 µl of bicinchonic acid is taken in an appender tube. To it, 10 µl of copper sulphate is added 
and mixed. 
• Dilutuions of  protein standards. 
A single protein is considered for the determination of the ideal drop size and lay over time. A 
series of dilutions were made. 20 µl of protein standard was taken and to it, 10 µl of PBS was 
added. This gives 20 µl/ml. From that, 0.5 µl/ml is prepared and used for further studies. 
Determination of Ideal drop size: 
It is important to determine the ideal drop size. Precision and accuracy are mainly 
considered to conclude.  
5 µl of the protein and 5 µl of BCA were mixed on a Para film and allowed to develop for 10 
minutes. Then 5 µl of this is pipetted on the take 3 plate with the help of a micro pipette. This is 
the test for 5 µl drop size.  In the similar fashion, 4 µl 3 µl, and 2 µl droplet sizes were checked. 
Three trails were carried to ensure precision. Results were recorded in Table set 1 for 5µl droplet 
size, table 2 for 4µl droplet size, table 3 for 3µl droplet size, table 4 for 5µl droplet size. 
 
The relative standard deviations were good for the 3 µl drop size, thus on observing the results, 3 
µl drop size was observed to be optimum.  
 
Determination of quantity of protein to be added: 
For this case several trials were done and each trail was repeated thrice for precission. The 
variation in the quantity of protein was carried as such: 
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• 3 µl of 0.5 µg/ml protein and 7 µl of BCA. (table 5) 
• 4 µl of 0.5 µg/ml protein and 6 µl of BCA  (table 6) 
• 5 µl of 0.5 µg/ml protein and 5 µl of BCA (table 7) 
  
 
 
 
Determination of ideal development time: 
The above dilutions were allowed to develop for 10 min, and 20 minutes for the above tables. 
Three trails were done to check if the results were precise. The results were recorded in the tables 
8.1 (3 µl of 0.5 µg/ml protein and 7 µl of BCA.), 8.2(4 µl of 0.5 µg/ml protein and 6 µl of BCA), 
8.3 (5 µl of 0.5 µg/ml protein and 5 µl of BCA) for the 20 minute development time and 9.1(3µl 
of 0.5 µg/ml protein and 7 µl of BCA), 9.2 (4 µl of 0.5 µg/ml protein and 6 µl of BCA), 9.3 for 
10 minute development time. 
 
 
Analyzing the Proteins: 
The proteins that were selected to be analyzed are egg albumin, Trypsinogen, β-
lactoglobulin, Pepsin and lysozyme. 1µg/ml concentration of the given protein samples were 
prepared. This is done by accurately measuring 0.0050g of the protein and adding 5ml of PBS to 
the protein. This gives 1µg/ml solution. This is considered as the stock solution. From the stock 
solution, 500µl was taken and 500µl of PBS was added to give 0.5µg/ml dilution which is used in 
the further experimentation procedure. This is done for all the 5 proteins. 
 
A 2µg/ml BSA standard was prepared by mixing 10mg of BSA in 5 ml of PBS. This 
gives 2mg/ml. 0.75ml of 2µg/ml standard BSA was Mixed with 0.25 ml of PBS. This gives 
1.5mg/ml solution. The prepared proteins are now ready to analyze. 
 
A paraflim is taken and mixing is carried out on the paraflim. BCA is used as a blank. 
1.5mg/ml, 1mg/ml, 0.75mg/ml, 0.5mg/ml, 0.25mg/ml, 0.125mg/ml dilutions were made on the 
para flim by mixing required amounts of BSA and the BCA. 
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On the paraflim a 5µl of different concentations of BSA was taken and 5 µl of PBS was 
added to each drop. It was set aside for 5min and the color was allowed to develop. then 3 µl was 
taken from this drop with the help of micro pipette and pipetted on to the take 3 plate.  
 
• The results of the protein Egg albumin were recorded in the table 10.1, 10.2 and 10.3 
• The results of the protein β-lacto globulin was recorded in table 11.1, 11.2, 11.3 
• The results of the protein Lysozyme was recorded in table 12.1, 12.2, 12.3 
• The results of the protein pepsin was recorded in table 13.1, 13.2, 13.3 
• The results of the protein trypsinogen was recorded in table 14.1, 14.2, 14.3 
The absorbance was then recorded by using Epoch Microplate spectrophotometer. 
 
Experimentation with the 96 well plate: 
10µl of the different concentrations of BSA was added to each well. And 10µl of each 
protein was added. To all these well 10 µl of PBS was added. The plate was kept in the incubator, 
allowing the color to develop. The absorbance was obtained in the same way using the Epoch 
Microplate spectrophotometer. The results obtained were recorded in the table 15. 
 
Results and discussion: 
We used BCA assay to quantify the protein sample with the help of newly 
introduced take-3 micro plate as a better linearity was observed in it compared to the 
Bradford. Upon continuous trials, we came to know that the ideal droplet size was 3µl as 
it has good precision. These results were shown in table 1. The lowest amount of protein 
that is required to analyze a protein was observed to be 0.5µgs. The time allowed for the 
protein to develop a complex with the BSA reagent was 10 min. this was also proved in 
the previous experimentation by Hardhik and Yougesh.   
With the help of the developed method, 5 proteins were analyzed. Egg albumin showed very 
good response. The concentration obtained matched well with the standard of 0.5µg/ml. the graph 
showed good linearity. (Table 10.1, 10.2, 10.3).  
The data obtained for the β-lacto globulin (table 11.1, 11.2, 11.3) resulted in good R2 and the 
concentration was observed to be 0.8µg/ml. 
The concentration of the other protein Lysozyme was observed to be 1.2 and the R2 was 0.98 
which is a good response. 
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the results of pepsin showed the concentration to be 0.3µg/ml and the R2 was 9.7 which is 
acceptable. 
The response of Trypsinogen was studied and the concentration was found to be 1.24µg/ml and 
with a good R2  response of 0.98 
The results thus obtained by the micro plate assay are compared to the results 76 well plate (table 
16). The results obtained were pretty close and hence the micro drop assay was observed to be 
effective. 
Funding:  
This research work was funded by combination of personal funds of Dr. Henne A 
Walter and Chemistry of department of Governors State University. 
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Table 1 
TRIAL 1 TRIAL 2 TRIAL 3 
0.046 0.034 0.032 0.033 0.035 0.033 
0.081 0.082 0.061 0.061 0.087 0.09 
0.09 0.082 0.054 0.059 0.082 0.088 
0.082 0.078 0.052 0.057 0.083 0.088 
0.081 0.088 0.06 0.057 0.089 0.087 
0.074 0.088 0.051 0.057 0.068 0.074 
0.131 0.083 0.059 0.056 0.07 0.076 
0.092 0.085 0.066 0.061 0.074 0.074 
 
 
STD MEAN R2 
Trial 1 0.017889 0.054375 15.59435 
Trial 2 0.025978 0.070877 6.8538 
Trial 3 0.02831 0.066387 9.60204 
Table 2 
 
Trial 1 Trial 2 Trial 3 
0.033 0.032 0.033 0.034 0.033 0.033 
0.061 0.068 0.066 0.067 0.068 0.092 
0.064 0.068 0.067 0.066 0.068 0.085 
0.061 0.069 0.068 0.074 0.075 0.077 
0.073 0.064 0.065 0.066 0.066 0.075 
0.055 0.064 0.066 0.064 0.073 0.077 
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0.065 0.085 0.067 0.067 0.068 0.076 
0.058 0.063 0.065 0.064 0.068 0.07 
 
 
  Trial 1 Trial 2 Trial 3 
STD 0.01475 0.002825 0.015023 
Mean 0.0598 0.065 0.0598 
Rel stdev 11.04139 4.19334 9.8525 
 
Table 3 
 
Trial 1 Trial 2 Trial 3 
0.033 0.05 0.032 0.032 0.034 0.033 
0.069 0.068 0.057 0.075 0.071 0.077 
0.059 0.071 0.058 0.065 0.062 0.069 
0.06 0.069 0.058 0.065 0.063 0.074 
0.073 0.063 0.071 0.07 0.069 0.076 
0.053 0.065 0.065 0.066 0.066 0.074 
0.056 0.069 0.059 0.057 0.068 0.071 
0.066 0.063 0.056 0.06 0.069 0.073 
 
  Trial 1 Trial 2 Trial 3 
STD 0.00588 0.00603 0.004504 
Mean 0.0645 0.063 0.070143 
Rel stdev 9.1058 9.5846 6.421134 
Table 4: 
 
Trial 1 Trial 2 Trial 3 
0.034 0.034 0.034 0.048 0.034 0.034 
0.067 0.068 0.072 0.08 0.066 0.07 
0.063 0.076 0.065 0.064 0.066 0.079 
0.062 0.069 0.062 0.07 0.058 0.066 
0.074 0.072 0.074 0.072 0.077 0.06 
0.078 0.07 0.058 0.064 0.062 0.091 
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0.07 0.071 0.066 0.057 0.069 0.072 
0.069 0.072 0.06 0.091 0.06 0.072 
 
 
  Trial 1 Trial 2 Trial 3 
STD 0.00441 0.009242 0.008883 
Mean 0.07007 0.068214 0.069143 
Rel stdev 6.29486 13.54829 12.84678 
Table 5: 
trial 1 trial 2 trial 3 
0.06 0.077 0.074 0.054 0.036 0.035 
0.06 0.066 0.068 0.058 0.057 0.069 
0.055 0.067 0.072 0.07 0.056 0.066 
0.057 0.067 0.084 0.069 0.048 0.057 
0.058 0.064 0.07 0.055 0.059 0.056 
0.064 0.066 0.066 0.058 0.049 0.06 
0.063 0.067 0.07 0.068 0.054 0.053 
0.035 0.037 0.036 0.036 0.052 0.053 
 
  trial 1 trial 2 trial 3 
mean 0.063643 0.066857 0.053635 
STDEV 0.005555 0.008189 0.005852 
% RSD 8.729047 12.24807 10.38398 
 
 
Table 6: 
trial 1 trial 2 trial 3 
0.034 0.038 0.036 0.034 0.035 0.034 
0.079 0.09 0.073 0.074 0.072 0.083 
0.065 0.08 0.065 0.078 0.069 0.086 
0.064 0.069 0.069 0.075 0.069 0.081 
0.066 0.073 0.094 0.085 0.085 0.079 
0.062 0.067 0.077 0.078 0.071 0.076 
0.071 0.073 0.078 0.073 0.079 0.079 
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0.073 0.076 0.07 0.076 0.075 0.079 
 
  trial 1 trial 2 trial 3 
mean 0.07200 0.076071 0.077357 
std 0.007545 0.007054 0.005583 
%rsd 10.4788 9.2733 7.217226 
 
 
Table 7: 
trial 1 trial 2 trial 3 
0.138 0.117 0.035 0.035 0.034 0.035 
0.088 0.107 0.073 0.073 0.078 0.079 
0.101 0.093 0.066 0.085 0.069 0.077 
0.11 0.098 0.068 0.069 0.064 0.076 
0.105 0.093 0.067 0.074 0.073 0.07 
0.099 0.094 0.071 0.063 0.076 0.077 
0.096 0.089 0.059 0.064 0.068 0.077 
 
  trial 1 trial 2 trial 3 
mean 0.1024 0.068714 0.0745 
std 0.01283 0.00639 0.004183 
%rsd 12.53222 9.299725 5.61516 
 
 
 
 Table 8.1 
trial 1 trial 2 trial 3 
0.059 0.06 0.036 0.036 0.037 0.038 
0.057 0.066 0.065 0.061 0.08 0.116 
0.061 0.058 0.06 0.067 0.078 0.071 
0.058 0.062 0.061 0.06 0.073 0.075 
0.055 0.067 0.061 0.096 0.099 0.07 
0.064 0.066 0.063 0.059 0.1 0.072 
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  trial 1 trial 2 trial 3 
mean 0.061143 0.0655 0.088357 
stdev 0.00388 0.01037 0.018092 
%rsd 6.345909 15.8319 20.4761 
 
 
 
Table 8.2 
trial 1 trial 2 trial 3 
0.035 0.035 0.035 0.035 0.034 0.034 
0.095 0.109 0.074 0.087 0.099 0.086 
0.096 0.103 0.069 0.076 0.086 0.099 
0.104 0.117 0.073 0.08 0.086 0.115 
0.108 0.094 0.079 0.082 0.091 0.137 
0.133 0.095 0.074 0.077 0.125 0.111 
0.139 0.09 0.073 0.077 0.101 0.096 
0.11 0.092 0.072 0.078 0.139 0.096 
 
  trial 1 trial 2 trial 3 
mean 0.106071 0.0765 0.104786 
stdev 0.014984 0.004604 0.018069 
%rsd 14.12673 6.014661 17.24377 
 
 
Table 8.3 
trial 1 trial 2 trial 3 
0.044 0.043 0.034 0.034 0.035 0.035 
0.064 0.071 0.106 0.108 0.109 0.1 
0.06 0.126 0.098 0.134 0.1 0.099 
0.059 0.054 0.1 0.101 0.101 0.096 
0.062 0.053 0.141 0.099 0.098 0.097 
0.102 0.055 0.107 0.096 0.101 0.091 
0.058 0.056 0.109 0.095 0.094 0.095 
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0.058 0.053 0.098 0.094 0.149 0.091 
 
  trial 1 trial 2 trial 3 
mean 0.0665 0.106143 0.1015 
stdev 0.02122 0.014212 0.014426 
%rsd 31.9091 13.38941 14.21301 
 
 
Table 9.1 
trial 1 trial 2 trial 3 
0.033 0.034 0.04 0.036 0.035 0.035 
0.08 0.07 0.057 0.067 0.07 0.066 
0.071 0.077 0.057 0.093 0.068 0.067 
0.075 0.072 0.059 0.057 0.069 0.064 
0.078 0.069 0.058 0.064 0.078 0.064 
0.076 0.076 0.058 0.065 0.072 0.063 
0.079 0.081 0.065 0.065 0.071 0.064 
0.073 0.074 0.056 0.066 0.101 0.066 
 
  trial 1 trial 2 trial 3 
mean 0.075071 0.063357 0.068267 
stdev 0.003751 0.009443 0.004832 
%rsd 4.996828 14.9044 7.078755 
 
 
 
Table 9.2 
trial 1 trial 2 trial 3 
0.035 0.046 0.037 0.035 0.036 0.035 
0.056 0.071 0.096 0.125 0.085 0.087 
0.06 0.065 0.085 0.09 0.088 0.083 
0.062 0.07 0.083 0.083 0.08 0.081 
0.068 0.062 0.098 0.083 0.084 0.074 
0.058 0.069 0.086 0.082 0.073 0.079 
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0.063 0.063 0.087 0.083 0.078 0.088 
0.067 0.065 0.085 0.081 0.09 0.084 
 
 
  trial 1 trial 2 trial 3 
mean 0.064214 0.089071 0.082429 
stdev 0.004492 0.011532 0.005199 
%rsd 6.995892 12.94728 6.307672 
Table 9.3: 
trial 1 trial 2 trial 3 
0.077 0.088 0.033 0.044 0.034 0.035 
0.087 0.088 0.072 0.071 0.076 0.077 
0.085 0.087 0.068 0.073 0.076 0.087 
0.086 0.083 0.065 0.133 0.076 0.078 
0.101 0.08 0.071 0.067 0.073 0.074 
0.09 0.081 0.077 0.078 0.085 0.08 
0.077 0.081 0.075 0.077 0.082 0.076 
0.089 0.072 0.08 0.075 0.077 0.075 
 
  trial 1 trial 2 trial 3 
mean 0.0834 0.073 0.078 
stdev 0.005262 0.004546 0.004095 
%rsd 6.309019 6.22748 5.250032 
 
Table10.1    
Trial 1 
 0.04 0.042 
0.046 0.053 
0.056 0.061 
0.074 0.073 
0.115 0.097 
0.116 0.116 
0.077 0.076 
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Table 10.2 
Trial 2 
0.037 0.037 
0.05 0.053 
0.067 0.066 
0.078 0.084 
0.107 0.098 
0.111 0.108 
0.162 0.124 
 
 
 
Table 10.3 
Trial 1 
0.035 0.037 
0.051 0.048 
0.078 0.066 
0.074 0.078 
y = 0.0785x + 0.04
R² = 0.9867
0
0.02
0.04
0.06
0.08
0.1
0.12
0.14
0.16
0.18
0 0.5 1 1.5 2
Series1
Linear (Series1)
y = 0.0481x + 0.0466
R² = 0.9885
0
0.02
0.04
0.06
0.08
0.1
0.12
0.14
0 0.5 1 1.5 2
21 | P a g e  
 
0.11 0.104 
0.105 0.089 
0.168 0.124 
0.075 0.086 
 
 
 
 
 
 
Table 11.1 
Trial 1 
0.035 0.035 
0.044 0.046 
0.065 0.065 
0.087 0.083 
0.109 0.093 
0.076 0.071 
 
 
y = 0.0828x
R² = 0.9748
0
0.02
0.04
0.06
0.08
0.1
0.12
0.14
0 0.5 1 1.5 2
22 | P a g e  
 
 
 
 
 
Table 11.2 
 
Trial 2 
0.036 0.037 
0.045 0.045 
0.058 0.071 
0.087 0.087 
0.093 0.089 
0.079 0.072 
 
 
 
 
 
Table 11.3 
y = 0.051x
R² = 0.9907
0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0.09
0 0.5 1 1.5 2
y = 0.0423x
R² = 0.9483
0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0 0.5 1 1.5 2
23 | P a g e  
 
Trial 3 
0.036 0.036 
0.043 0.047 
0.063 0.066 
0.068 0.08 
0.09 0.087 
0.067 0.07 
 
 
 
 
 
Table 12.1 
Trial 1 
0.036 0.037 
0.046 0.044 
0.061 0.069 
0.079 0.081 
0.099 0.088 
0.088 0.094 
 
 
 
 
Table 12.2 
y = 0.043x
R² = 0.986
0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6
24 | P a g e  
 
Trial 2 
0.035 0.035 
0.043 0.044 
0.056 0.064 
0.069 0.081 
0.103 0.094 
0.088 0.089 
 
 
 
 
Table 12.3 
 
Trial 3 
0.035 0.035 
0.044 0.045 
0.057 0.071 
0.077 0.083 
0.108 0.096 
0.09 0.098 
 
 
y = 0.042x
R² = 0.9662
0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6
25 | P a g e  
 
 
 
 
 
Table 13.1 
 
Trial 1 
0.04 0.039 
0.045 0.044 
0.053 0.067 
0.066 0.081 
0.081 0.087 
0.056 0.053 
 
 
 
y = 0.0465x
R² = 0.9875
0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6
y = 0.0269x
R² = 0.9963
0
0.005
0.01
0.015
0.02
0.025
0.03
0.035
0.04
0.045
0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6
26 | P a g e  
 
Table 13.2 
 
Trial 2 
0.037 0.037 
0.041 0.049 
0.056 0.066 
0.076 0.078 
0.094 0.09 
0.048 0.049 
 
 
 
Table 13.3 
 
Trial 3 
0.037 0.037 
0.039 0.044 
0.05 0.058 
0.059 0.068 
0.091 0.086 
0.046 0.048 
 
 
y = 0.0383x
R² = 0.9994
0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0 0.5 1 1.5 2
27 | P a g e  
 
 
 
 
Table 14.1 
 
Trial 1 
0.034 0.034 
0.043 0.047 
0.05 0.059 
0.082 0.131 
0.094 0.088 
0.082 0.088 
 
 
 
 
y = 0.033x
R² = 0.9784
0
0.01
0.02
0.03
0.04
0.05
0.06
0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6
y = 0.0418x
R² = 0.9689
0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0 0.5 1 1.5 2
28 | P a g e  
 
Table 14.2 
 
Trial 2 
0.035 0.034 
0.047 0.046 
0.06 0.067 
0.088 0.084 
0.108 0.09 
0.097 0.096 
 
 
 
 
Table 14.3 
Trial 3 
0.036 0.036 
0.042 0.044 
0.056 0.062 
0.072 0.082 
0.107 0.095 
0.089 0.092 
 
 
y = 0.0502x
R² = 0.9872
0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6
29 | P a g e  
 
 
 
 
 
 
Table 15 
Full plate assay 
0.067 0.068 
0.106 0.112 
0.22 0.221 
0.336 0.336 
0.486 0.487 
0.239 0.242 
0.31 0.311 
0.21 0.21 
0.151 0.154 
0.339 0.345 
 
y = 0.0422x
R² = 0.974
0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6
30 | P a g e  
 
 
 
 
 
Fig 1 
 
 
Fig 2: 
 
 
y = 0.2784x
R² = 0.9975
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
0.45
0 0.5 1 1.5 2
31 | P a g e  
 
Fig 3: 
 
 
 
Fig 4: 
 
 
                                                    
 
 
